Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: With mean follow-up of 3.5 years

1 Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the national cancer data base European Urology, May 8, 2013

2 The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence? World Journal of Urology, May 6, 2013    Review Article

3 Interferon α in the treatment paradigm for non–muscle-invasive bladder cancer Urologic Oncology: Seminars and Original Investigations, May 1, 2013

4 The Role of Laparoscopy in the Management of Liver Hydatid Cyst: A Single-center Experience and World Review of the Literature Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, April 30, 2013    Review Article

5 Treating octogenarians with muscle-invasive bladder cancer: Preoperative opportunities for increasing the benefits of surgical intervention Urologic Oncology: Seminars and Original Investigations, May 14, 2013    Review Article

6 The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer International Urology and Nephrology, May 14, 2013    Review Article

7 The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy European Urology, May 15, 2013

8 Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis The Journal of Urology, May 3, 2013

9 Bladder cancer: Biomarker panel predicts recurrence after radical cystectomy Nature Reviews Urology, May 7, 2013

10 Pseudoneoplastic mimics in an inactive bladder associated with ureteral strictures International Braz J Urol, May 3, 2013